关联SCN1A基因多态性与儿童的酸耐药性:一个回顾性病例对照研究
Huiyu Wang1, Tingting Geng1, Na Deng1
1Department of Pediatric Intensive Care Unit, Shiyan Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei Province, People's Republic of China.
SCN1A基因的遗传变异与儿科的抗性有关. 特定的SCN1A突变与降低药物疗效和增加发作的严重程度相关,为个性化治疗铺平了道路.
科学领域:
- 遗传学 是一个遗传学.
- 药物基因组学 药物基因组学
- 儿科神经学 儿科神经学
背景情况:
- 影响了中国人口的很大一部分,很大一部分人经历了抗药物的耐药性.
- 了解氨酸耐药性的遗传因素对于开发儿童的个性化治疗策略至关重要.
研究的目的:
- 调查SCN1A基因多态性和儿科患者的氨酸耐药性之间的关联.
- 探索这些多形态对血中氨酸度和发作类型的影响.
主要方法:
- 对89名患有耐药性的儿科患者,89名患有耐药性的儿科患者和89名健康对照患者的回顾性分析.
- 对SCN1A基因多态的分析和跨组的比较.
- 评估血中氨酸度和多变量逻辑回归以确定抗性因子.
主要成果:
- 在五个位点 (rs166859148, rs166894396, rs166848482, rs166915162, rs166870333-335) 之间发现了SCN1A基因型分布的显著差异.
- 这些位点的突变与甲抗性相关,对于rs166915162和rs166870333-335,与较低的血甲水平有关.
- rs166870333-335变种也与药物耐药患者的普遍性型相关.
结论:
- SCN1A基因突变,特别是RS166859148,RS166894396,RS166848482,RS166915162和RS166870333-335的突变,可能会导致儿科的抗性.
- 在rs166915162和rs166870333-335中的突变与血中氨酸水平的降低有关.
- rs166870333-335突变与药物耐药性的普遍性发作类型有关,强调了其临床意义.
更多相关视频
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
